Login to Your Account

Financings Roundup

'Gates' Swing Open to $30M in Genocea Series C Funding

By Randy Osborne
Staff Writer

Thursday, October 11, 2012
Vaccines-focused Genocea Biosciences Inc. added the Bill & Melinda Gates Foundation to its backers as part of a $30 million Series C round that will help advance malaria work, along with programs in herpes simplex virus-2 and Streptococcus pneumoniae.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription